Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Terminated × Pain × Acetaminophen × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Completed 9 Unknown 2 Terminated 2 Recruiting 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Pain 2 Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Trigger Finger Disorder 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Mesothelioma 1 Median Neuropathy 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Leukemia 1 Head and Neck Neoplasms 1 Ganglion Cysts 1 Emergence Delirium 1 Delirium 1 De Quervain Disease 1 Carcinoma 1 Burkitt Lymphoma 1

Interventions

Morphine 7 Fentanyl 5 Radiotherapy 4 Methadone 4 Zoledronic Acid 3 Tapentadol 2 Ropivacaine 2 Pregabalin 2 Prednisone 2 Ketamine 2 Ibandronic Acid 2 Hydromorphone 2 Glutamine 2 Cryotherapy 2 Cryosurgery 2 Bupivacaine 2 Acupuncture Therapy 2 Acetaminophen 2 pegfilgrastim 1 oxycodone naloxone combination 1 naloxegol 1 ixabepilone 1 incobotulinumtoxinA 1 imisopasem manganese 1 cyclobenzaprine 1 cabozantinib 1 acetaminophen, aspirin, caffeine drug combination 1 Zolpidem 1 Surveys and Questionnaires 1 Sugars 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05088876 2026-04-13

ParOP

Insel Gruppe AG, University Hospital Bern

Phase 4 Terminated

Pain

NCT02706769 2019-09-27

PaSO

University of Edinburgh

Phase NA Terminated

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡